Impact of the integration of proton magnetic resonance imaging spectroscopy to PI-RADS 2 for prediction of high grade and high stage prostate cancer

Impacto da incorporação da espectroscopia por ressonância magnética ao PI-RADS 2 para a predição de câncer de próstata de alto grau e de estágio avançado

Michael S. Leapman¹; Zhen J. Wang²; Spencer C. Behr²; John Kurhanewicz³; Ronald J. Zagoria²; Peter R. Carroll⁴; Antonio C. Westphalen⁵

• Article
• About the authors
• Statistics
• Comments
• Related content

This work is licensed under an Attribution 4.0 International License (CC BY 4.0), effective June 9, 2022. Previously, the journal was licensed under a Creative Commons Attribution - Non-Commercial - Share Alike 4.0 International License.